Hycult Biotech

Founded in 1994, Hycult Biotech develops and manufactures immunological research reagents with a particular focus on complement biology, innate immunity and inflammation. As an ISO 13485-certified manufacturer, the company combines expertise in antibody development, assay design and protein production to support the study of host defence mechanisms, immune regulation and disease-associated inflammatory processes. Its technologies enable researchers to detect, quantify and characterise key biomarkers involved in complement activation, cytokine signalling, antimicrobial responses, coagulation and thrombo-inflammation. Hycult Biotech products are widely used in academic, translational and preclinical research, supporting applications across immunology, infectious disease, cardiovascular research and inflammatory disorders.

The company’s portfolio includes monoclonal and polyclonal antibodies, ELISA kits, functional assays, recombinant proteins, peptides and secondary reagents. Hycult Biotech is particularly recognised for its extensive range of complement research tools, including assays for analysing complement pathways, activation products and immune mediators in human and animal samples. These products support workflows such as biomarker measurement, pathway analysis, flow cytometry, immunohistochemistry, immunofluorescence and western blotting.

Europa Biosite’s subsidiaries distribute for Hycult Biotech in Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, and the United Kingdom.